Adeshwar Meditex revenue falls 33% in FY26; net profit down 39%

scanx
Reviewed by
Ashish TScanX News Team
Key Highlights
  • Revenue from operations fell 33% YoY to ₹5,610.38 lakh in FY26
  • Net profit after tax declined 39% to ₹126.49 lakh
  • New statutory auditors appointed for five-year term starting FY26
  • Trade payables dropped significantly to ₹482.54 lakh from ₹2,121.40 lakh
powered bylight_fuzz_icon
48955070

*this image is generated using AI for illustrative purposes only.

Adeshwar Meditex reported a significant contraction in financial performance for FY26, with revenue from operations falling 33% year-on-year to ₹5,610.38 lakh. Net profit after tax declined 39% to ₹126.49 lakh, reflecting broader operational headwinds in the medical consumables sector.

The company concluded its Board of Directors meeting on August 26, 2026, approving key governance changes including the appointment of M/s. Shankar Ramesh & Co. LLP as statutory auditors for five years (FY26-FY31). This replaces retiring auditor M/s. Rajesh H. Gupta & Co., who served during the period under review.

Financial Performance

Revenue from operations dropped from ₹8,371.31 lakh in FY25 to ₹5,610.38 lakh in FY26. Total expenses decreased proportionally to ₹5,437.57 lakh from ₹8,117.83 lakh in the previous year. Consequently, profit before tax fell to ₹183.19 lakh from ₹279.34 lakh.

Metric FY26 FY25 Change
Revenue from operations ₹5,610.38 lakh ₹8,371.31 lakh -33%
Total Expenses ₹5,437.57 lakh ₹8,117.83 lakh -33%
Profit Before Tax ₹183.19 lakh ₹279.34 lakh -34%
Net Profit After Tax ₹126.49 lakh ₹206.57 lakh -39%

Earnings per share (basic) stood at ₹0.88, down from ₹1.43 in FY25. The company did not declare any dividend for the year, aiming to conserve resources for future growth.

Governance Changes

Ms. Bhagyalaxmi Kavital was appointed as an additional Non-Executive Independent Director effective May 21, 2026, subject to shareholder approval at the upcoming AGM. Her profile highlights experience in managerial finance functions and AI applications in accounts.

Mr. Prithvi Singh resigned as a Non-Executive Director effective August 26, 2026. Additionally, M/s. Basude Makote & Saini resigned as internal auditors, replaced by M/s. Saini & Makote for FY27.

AGM Logistics

The 19th Annual General Meeting is scheduled for Wednesday, September 23, 2026, at 12:30 pm. The register of members will remain closed from September 17, 2026, to September 23, 2026. Mr. Deep Shukla was appointed as scrutinizer for the e-voting process.

What the Numbers Show

The decline in revenue was accompanied by a sharper drop in other income, which fell to ₹10.39 lakh from ₹25.86 lakh in FY25. This suggests reduced non-operating gains contributed to the overall profit compression, alongside lower operational scale. Working capital management improved significantly, with trade payables dropping to ₹482.54 lakh from ₹2,121.40 lakh, indicating better supplier payment cycles or reduced procurement volumes.

Historical Stock Returns for Adeshwar Meditex

1 Day5 Days1 Month6 Months1 Year5 Years
+3.30%+3.30%0.0%0.0%0.0%0.0%

What specific strategic initiatives is Adeshwar Meditex planning to implement to reverse the 33% revenue decline and regain market share in the medical consumables sector?

How might the appointment of an independent director with expertise in AI applications influence the company's operational efficiency and financial forecasting accuracy in upcoming fiscal years?

Given the significant reduction in trade payables, does this indicate a deliberate shift in supplier negotiation strategies or a contraction in raw material procurement due to lower demand?

Adeshwar Meditex accepts Prithvi Singh resignation as director

scanx
Reviewed by
Ashish TScanX News Team
Key Highlights
  • Adeshwar Meditex accepts resignation of Non-Executive Director Prithvi Singh
  • Resignation effective August 26, 2026, due to personal commitments
  • Director cites pursuit of MD Radio Diagnosis course as reason
  • Disclosed under Regulation 30 of SEBI Listing Regulations
powered bylight_fuzz_icon
49376825

*this image is generated using AI for illustrative purposes only.

Adeshwar Meditex has accepted the resignation of Mr. Prithvi Singh from the position of Non-Executive Director, effective August 26, 2026. The company disclosed the change to the Bombay Stock Exchange on August 27, 2026.

Mr. Singh cited personal commitments as the primary reason for his departure. In his resignation letter, he further noted that he is pursuing a postgraduate course in MD Radio Diagnosis, which requires his full attention.

Regulatory Disclosure

The company made the disclosure pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The filing confirms that there are no other material reasons for the resignation beyond those stated in the letter dated August 26, 2026.

Director Profile

Mr. Singh served as a member of the Nomination and Remuneration Committee during his tenure. The board has acknowledged receipt of his resignation and confirmed that he holds no other directorships in listed entities apart from Adeshwar Meditex.

Historical Stock Returns for Adeshwar Meditex

1 Day5 Days1 Month6 Months1 Year5 Years
+3.30%+3.30%0.0%0.0%0.0%0.0%

Will Adeshwar Meditex initiate an immediate search for a new Non-Executive Director to maintain board stability?

How might the departure of a member from the Nomination and Remuneration Committee impact ongoing governance decisions?

Are there any pending strategic initiatives or committee approvals that could be delayed due to this leadership change?

More News on Adeshwar Meditex

1 Year Returns:0.00%